Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
about
Central venous catheter (CVC) removal for adult patients with candidaemiaAntifungal agents for preventing fungal infections in non-neutropenic critically ill patientsPhase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemiaVancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factorsPrevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002Polyadenylation of ribosomal RNA by Candida albicans also involves the small subunitIdentification of Drosophila gene products required for phagocytosis of Candida albicansLaboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United StatesCentral venous catheter (CVC) removal for patients of all ages with candidaemiaThe Host's Reply to Candida BiofilmCandida Biofilms: Development, Architecture, and ResistanceAssociation of genotypes with infection types and antifungal susceptibilities in Candida albicans as revealed by recent molecular typing strategiesReal-time PCR in clinical microbiology: applications for routine laboratory testing.Structure of Candida albicans methionine synthase determined by employing surface residue mutagenesisCrystal Structures of Candida albicans Dihydrofolate Reductase Bound to Propargyl-Linked Antifolates Reveal the Flexibility of Active Site Loop Residues Critical for Ligand Potency and SelectivityRegulatory roles of phosphorylation in model and pathogenic fungiLife and death in a macrophage: role of the glyoxylate cycle in virulenceEthanolamine activates a sensor histidine kinase regulating its utilization in Enterococcus faecalisAntimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assaySmall molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathwaysDevelopment of a high-throughput Candida albicans biofilm chipAccumulation of Pyrimidine Intermediate Orotate Decreases Virulence Factor Production in Pseudomonas aeruginosaSensitivity of clinical isolates of Candida to essential oils from Burseraceae familyBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaEpidemiology of invasive candidiasis: a persistent public health problemEpidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.Architectural design influences the diversity and structure of the built environment microbiome.Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobiaExcess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.Inhibition of biofilm formation and swarming of Bacillus subtilis by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone.Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.Identification of a new family of genes involved in beta-1,2-mannosylation of glycans in Pichia pastoris and Candida albicans.Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.ABG1, a novel and essential Candida albicans gene encoding a vacuolar protein involved in cytokinesis and hyphal branching.Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.The parasexual cycle in Candida albicans provides an alternative pathway to meiosis for the formation of recombinant strains.Linezolid-Induced anemia and thrombocytopenia.Thrombocytopenia associated with linezolid therapy.
P2860
Q24195090-A8D64B88-B473-4C2F-AB78-54712C2AD083Q24244555-C3F5EEE2-DF59-453D-9EB6-453A6976FBADQ24563657-48A31DED-10E5-443C-AF0F-9DC2D0F3737BQ24678140-FDD3B390-DB99-4225-8F5E-68D6B5317C3BQ24791698-071B1CC1-321C-4C13-A424-AC701DEF52FBQ24799836-92E7F610-F99F-4310-A574-AE5C63B8E4EAQ24810538-BF2BCCCE-8B3A-41C2-BA8D-70AA901EE400Q25257335-72E3EF33-01B8-432D-A17F-2C16D29CF521Q26471135-C56B8E2C-A65A-4630-82BA-8CDAF6598D56Q26752938-565A3F5F-FE19-4B31-9559-5E0FBC746FDBQ26782611-2D92668C-0652-4B61-9709-12DC9D8D0632Q27023720-C033B243-3344-463B-944A-3E1CC94C9F90Q27472851-B7EBDB1F-9AC1-4156-9AC1-72FF5FF2A54EQ27670484-3336A572-C5D4-4465-B4BA-7E7F727BB407Q27670663-32BBA45D-A006-494E-8829-89FBD7588960Q28087413-DB724729-3E76-405B-AE30-75F968ED732FQ28216197-B7E2E9CD-95AA-4D39-AB85-0F44CA74689BQ28293257-2241079D-B472-4016-A3B6-E9BBAF918781Q28366760-C0ABA29F-3EA4-46AD-9209-5ECA6A820702Q28476138-1266B2AA-6AC9-4F91-A555-7842E63497F6Q28477230-AF0388A7-3919-445F-9790-4C07F8004CC6Q28477874-9054B81E-7A29-401A-8D92-7D48F59CAAC6Q28492936-173E4BAB-163C-4D1B-BA3D-1CD44ED7E1D2Q28830247-A438FB47-008E-401C-8D00-A313AC859377Q29616084-D8B2AE44-2765-4756-BCF4-81B51B1267ACQ29616758-88A9FA3C-EB08-4DD3-A6D9-309DA900C4A4Q30350496-22B6BD99-6D10-425B-9076-B1177AAA8BBEQ30394950-0635CE83-0D4D-4FFE-974C-1EA740C16F4AQ30453032-348227C9-F1C5-4ABD-AB75-0E0F9B205D13Q30453797-6EA4D32E-F8A2-401B-BC13-A4A86B852223Q30994297-5C350126-3CE7-45B8-9B15-2497825A7CEFQ31047907-A0899458-4B05-47FF-B272-82205D4391BDQ31114184-F8A2513B-7A3F-476E-8777-2F1E849C2725Q31144786-2DC29188-C26C-4DEA-A6A1-B012CF19AEA4Q33183542-E1D77988-A40C-49E7-8E4B-FDF33080831EQ33216798-BB0D2EEC-B5D3-4EB4-8F58-B9C628871927Q33239546-E7647710-E212-4E17-B832-E293EB9B34C2Q33332302-94B2E1ED-4512-4F73-815D-586EB7AC8A32Q33340618-1CE17A7C-933C-4DE6-BD09-222FCCB0DFB2Q33340707-2195CF3B-8CD6-4FF9-AC79-73D03C393FA9
P2860
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@en
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@nl
type
label
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@en
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@nl
prefLabel
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@en
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@nl
P2093
P356
P1476
Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
@en
P2093
P304
P356
10.1086/520192
P407
P577
1999-08-01T00:00:00Z